Market Research Report
Orthopedic Biomaterials Market Report Suite | Australia | 2020-2026 | Medsuite
|Published by||iData Research Inc.||Product code||925593|
|Published||Content info||285 Pages
Delivery time: 1-2 business days
|Orthopedic Biomaterials Market Report Suite | Australia | 2020-2026 | Medsuite|
|Published: February 7, 2020||Content info: 285 Pages||
The full report suite on the Australian market for orthopedic biomaterials includes bone graft substitutes, which are represented by allografts, demineralized bone matrix (DBM) allografts and synthetics. This report also includes orthopedic growth factors and hyaluronic acid (HA) viscosupplementation. The orthopedic biomaterials market includes bone graft substitutes, HA viscosupplementation and growth factors. In 2019, the largest segment was the orthopedic bone graft substitute market, which includes allografts, DBM allografts and synthetics. In Australia, synthetics are the most popular material for orthopedic bone graft substitute procedures, largely due to a limited supply of allografts and DBM allografts.